Skip to main content

Find Clinical Trials

Home
Conditions
Fatty Liver

Clinical trial condition

Fatty Liver

Explore clinical trials studying Fatty Liver. Study availability and eligibility vary by location and protocol.

953 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Fatty Liver trial results

Not Yet Recruiting

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

NCT07631637

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

NCT07570810

Conditions: Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)

NCT07466485

Conditions: Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Fatty Liver Disease, +7 more
Locations: Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak Cheras, Kuala Lumpur, Malaysia

View Trial Details

Not Yet Recruiting

RE and Probiotics in MAFLD/NAFLD

NCT06563921

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial

NCT07497750

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: CHU Angers Angers, France

APHP Hôpital Beaujon Clichy, France

CHU Dijon Hôpital Le Bocage Dijon, France

CHU Lyon Lyon, France

View Trial Details

Not Yet Recruiting

A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis

NCT03468556

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.

NCT07407634

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: The First Hospital of Jilin University Jilin City, Changchun, China

View Trial Details

Not Yet Recruiting

Human Models of Selective Insulin Resistance: Pancreatic Clamp

NCT06558422

Conditions: Body Weight, Diabetes Mellitus, Digestive System Diseases, +19 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Not Yet Recruiting

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

NCT03867487

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations: Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

NCT07310407

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: National Hepatology and Tropical Medicine Research Institute (NHTMRI) Cairo, Egypt

View Trial Details